Acute coronary syndrome without ST elevation: implementation of new guidelines
C W Hamm1, M Bertrand, E Braunwald
1Department of Cardiology, Kerckhoff Heart Center, Benekestrasse 2-8, D-61231 Bad Nauheim, Germany. Christian.Hamm@kerckhoff.med.uni-giessen.de
Lancet (London, England)
|November 14, 2001
Summary
New guidelines for unstable angina and non-ST-segment-elevation myocardial infarction incorporate troponins and new treatments. Early invasive management and clopidogrel show further benefits for high-risk patients.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Unstable angina and non-ST-segment-elevation myocardial infarction are key manifestations of coronary artery disease.
- Recent guidelines from European (ESC) and American (ACC/AHA) societies address diagnosis, risk stratification, and treatment.
Purpose of the Study:
- To summarize current evidence and clinical practice guidelines for unstable angina and non-ST-segment-elevation myocardial infarction.
- To highlight key updates and emerging findings in the management of these conditions.
Main Methods:
- Review and synthesis of current evidence and professional society guidelines.
- Analysis of recent study results impacting treatment strategies.
Main Results:
- Guidelines now include troponins in risk stratification.
- Low-molecular-weight heparin and glycoprotein IIb/IIIa antagonists are added to medical treatment.
- Invasive management plays a role in improving long-term outcomes.
Conclusions:
- Emerging evidence supports early invasive management and clopidogrel for high-risk patients.
- Professional societies will collaborate to update and implement revised guidelines.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...